is the fda banning compounded semaglutide moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Compounded Semaglutide: Legal & Safe

These check-ins are essential for adjusting dosage and ensuring the treatment is both safe and effective

Publication bias was evaluated using funnel plots for RCTs that provided data on the primary outcome, as shown in Supplemental Fig

For many patients, these medications are helping to achieve significant weight loss and improvements in overall health

Consequences of weight cycling: an increase in disease risk

Cantarel BL, Lombard V, Henrissat B

Early GLP-1 manufacturers, including Novo Nordisk and Eli Lilly, originally developed the drug to help with blood sugar control in adults with type 2 diabetes, but weight loss has since become the primary driver of adoption, he says